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Atopic asthma is a complex disease associated with IgE-mediated immune reactions. Numerous genome-wide studies identiﬁed
more than 100 genes in 22 chromosomes associated with atopic asthma, and diﬀerent genetic backgrounds in diﬀerent
environments could modulate susceptibility to atopic asthma. Current knowledge emphasizes the eﬀect of tobacco smoke on
the development of childhood asthma. This suggests that asthma, although heritable, is signiﬁcantly aﬀected by gene-gene and
gene-environment interactions. Evidence has recently shown that molecular mechanism of a complex disease may be limited to
not only DNA sequence diﬀerences, but also gene-environmental interactions for epigenetic diﬀerence. This paper reviews and
summarizes how gene-gene and gene-environment interactions aﬀect IgE production and the development of atopic asthma
in prenatal and childhood stages. Based on the mechanisms responsible for perinatal gene-environment interactions on IgE
production and development of asthma, we formulate several potential strategies to prevent the development of asthma in the
perinatal stage.
1.Introduction
Atopic asthma is a complex disease associated with IgE-
mediatedallergicreactions.MostallergenselicitIgEantibod-
ies, which bind to mast cells; when cross-linked, the mast cell
releases inﬂammatory mediators that cause bronchospasm
and mucus formation [1]. Nonatopic asthma refers to
inﬂammation and constriction of the airways that are not
caused by exposure to an allergen. As with numerous ill-
deﬁned diseases in which numerous extrinsic inﬂuences and
genetic factors contribute to onset of the disease, the term
“complex disease” is applied. Such terminology refers to
asthma as caused by a complex relationship between genetic
and environmental components, resulting in the clinical
manifestations of atopic asthma. Systemic administration of
humanized anti-IgE antibodies causes a 95–99% decrease in
serum IgE, along with anti-inﬂammatory feature of asthma
[2], which supports the IgE-mediated mechanism of atopic
asthma. Numerous genome-wide association (GWA) studies
have identiﬁed more than 100 genes in 22 chromosomes
associated with atopic asthma [3, 4]. Moreover, genetic
backgrounds and environmental exposures could modulate
susceptibility to asthma [5, 6]. This suggests that asthma,
although heritable, is signiﬁcantly aﬀected by environmental
factors. Evidence has recently shown that molecular mecha-
nisms of atopic disease may not be limited to DNA sequence
diﬀerences, but also gene-environmental interactions for
epigenetic diﬀerence and/or regulatory T cells (Treg) [7, 8].
We describe recent advances in our understanding based
on the mechanisms responsible for gene-gene and gene-
environment interactions on IgE production and develop-
ment of atopic asthma in the perinatal stage.2 Clinical and Developmental Immunology
Table 1: Gene-gene interactions on IgE production and asthma
phenotype.
Total IgE levels/ asthma phenotype Gene-gene interactions
Prenatal
IgE levels
(cord blood,
infant blood)
CD86-VTCN1 [9]
IL13-CCL17 [10]
IL1RL1-BPI [11]
TGFBR2-IL2RA [12]
IL13-CCL17-CXCL10 [10]
MD2-ITGB2-BPI [11]
Childhood
IgE levels
CD14-AOAH [13]
IL1RL1-NOD1 [11]
IL13-IL4RA [14, 15]
IL13-IL13RA1 [16]
IL13-TARC [17]
TLR2-TGFBR2 [12]
MD2-MAP3KIP2-BPI [11]
TLR2-IL6RA-IL2RA [12]
Asthma
CD14-AOAH [13]
CD274-LILRA4 [9]
GSNOR-B2AR [18]
IL4-IL4RA [19]
IL6-IL6R [20]
IL13-IL4R [21]
IL13-IL4RA [15, 17, 22]
LTA4H-ALOX5AP [23]
SOCS1-MAP3K7IP1 [11]
TNC-NPSR1 [24]
EPHX1-CYP1B1-CYP2D6
[25]
IL2RA-FOXP3-IL2RA [12]
IRAK1-NOD1-MAPK7IP1
[11]
STAT6-STAT4-IFNG [26]
TLR2-IL2RA-TGFBR2 [12]
B2AR-CCR3-CysLTR1-
FCER1B [27]
INSIG2-IL4-CHIA-ADIPOQ-
ALOX5 [28]
IL4-STUB1-ADRB2-IL4RA-
IL13RA2-CHIA [28]
2. Gene-GeneInteractionson IgE
ProductionandAsthma Development
Allergic diseases, including atopic asthma, have long been
attributed to IgE-mediated reactions, and elevation of serum
IgE levels has been correlated to allergic diseases [29, 30].
Allergic sensitization might occur in utero and be related to
thefuturedevelopmentofallergicdiseases[31,32].Elevation
of cord blood IgE (CBIgE), although not suﬃcient to predict
the development of allergic diseases in childhood [33, 34],
was shown to be a risk predictor for the development of
aeroallergen sensitization [35] and for later development of
childhood asthma [36]. Signiﬁcant associations with eleva-
tion of CBIgE levels were reported previously for cytotoxic
T-lymphocyte-associated protein 4 (CTLA4) +49A allele [37]
and for IL13, CCL17, and CXCL10 gene interactions [10].
Reijmerink et al. [11] used the multifactor dimensional-
ity reduction (MDR) analysis, which is designed to translate
high-dimensional genetic data into a single dimension, to
explorethegene-geneinteractionsonIgEproductionandthe
development of asthma. Interactions between these genes,
located in the Toll-like-receptors- (TLR-) related pathway,
showed that the polymorphisms in interleukin 1 receptor-like
1 (IL1RL1)a n dbactericidal/permeability-increasing protein
(BPI) were the optimal model of interaction using 2-way
MDR analysis (P = 0.02) to predict the elevation of total IgE
levels. The polymorphisms in myeloid diﬀerentiation factor
(MD)-2, beta-2 integrin (ITGB2), and BPI were identiﬁed as
the optimal model of the 3-way MDR analysis (P = 0.01) to
predict the elevation of total IgE levels at 1 to 2 years of age.
A number of gene-gene interactions implicating a link
between IgE production and the development of asthma in
the perinatal stage are shown in Table 1, in which more com-
plexinteractionsamongdiﬀerentimmunegenesarefoundin
asthma than in IgE production. Moreover, a kinetic change
of diﬀerent gene proﬁles associated with IgE production was
found in children with increasing ages. In our studies on
Chinese cohorts, IgE production in infancy and toddlerhood
was associated with immune and remodeling genes, and IgE
production in preschool age was associated with MHC class
II antigen genes, such as HLA-DPA1 and HLA-DQA1 (our
unpublisheddata).Theseresultssuggestthatalteredimmune
remodeling in infancy and toddlerhood may prime children
for allergic sensitization in childhood, depending on HLA
genotypes.
With the introduction of powerful novel genetic-analysis
tools, the heritable component of asthma has gained increas-
ing attention over the last decade. This attention calls for
open approaches to the linkage and GWA studies rather
than traditional candidate gene approaches to the genetics
of asthma. The main strength of GWA studies lies in their
ability to discover genuinely novel disease-candidate genes,
especially those associated with moderate risks [38]. In a
recent GWA study for asthma, Moﬀa t te ta l . genotyped more
than 317,000 single-nucleotide polymorphisms (SNPs) in
994patientswithchildhoodasthmaand1243peoplewithout
asthma, and identiﬁed that polymorphisms of ORM1-
like 3 (ORMDL3) on chromosome 17q21.1 were strongly
associated with childhood asthma [39]. The association was
also independently replicated in 2320 participants from a
cohortofGermanchildrenandin3301participantsfromthe
British 1958 birth cohort [39].
ORMDL3 appears to be a gene in a very old part of the
human genome, and similar genes were found in primitive
organisms such as yeast. Although the transcript level of
ORMDL3isstronglycorrelatedtosusceptibilitytochildhood
asthma, its role remains unclear. Additional GWA studies on
asthma are underway, and cross-validation data among these
studies may lead to better conclusions on the responsible
genes for the development of asthma.Clinical and Developmental Immunology 3
3. Gene-EnvironmentInteractionson IgE
ProductionandAsthma Development
Increasingly, more studies in the literature identify novel
genes associated with asthma and suggest that numerous
genes with small eﬀects rather than few genes with strong
eﬀects contribute to the development of asthma. These
genetic eﬀects may in part diﬀer with respect to a patient’s
environmental exposures. Several environmental factors,
such as maternal atopy, endotoxin, tobacco smoke, pollu-
tants, allergens, cold air, microbial infections, medication,
and exercise, are known to exacerbate asthma symptoms
[40–44]. Of these environmental factors, maternal atopy,
microbial exposure, and tobacco smoke exposure are partic-
ularly important and its gene-environment interactions are
described below.
3.1. Maternal Atopy. Allergy sensitization may occur in fetal
life. Moreover, the immature immune system is highly sus-
ceptible to immunomodulatory environmental conditions,
particularly in the prenatal and postnatal periods [45].
Maternal atopy may impact neonatal immune development
and subsequently alter the allergic responses of neonates. A
number of candidate gene studies investigating interactions
between maternal atopy and airway hyperresponsiveness
have also been performed for 3 main groups of genes:
immunitygenes(CD14,IL13,CCL22,andCTLA4),thestress
gene (ﬁbroblast growth factor 1 (FGF-1)), and the MHC
class I antigen gene (HLA-G) gene. Speciﬁcally, maternal
but not paternal atopy has a signiﬁcant impact on CBIgE
elevation, depending on the gender and CTLA4 +49A/G
polymorphism of newborns [46]. Maternal atopy interacting
with the polymorphisms in IL13 and CCL22 genes was
reported to be a good predictor of CBIgE elevation [10].
In contrast, in the absence of maternal atopy, the CTLA4
+49GG genotype in female newborns had a protective eﬀect
on CBIgE elevation [46].
3.2. Microbial Exposure. The prevalence of asthma is widely
skewed in developed and developing countries, the reasons
for which remain obscure. The hygiene hypothesis has
emerged as a popular explanation. The hygiene hypothesis
was initially developed to explain a reduced rate of allergic
diseases among children with older siblings [56]. The under-
lying concept is that an increased exposure to microbes and
their products during the perinatal stage protects against the
developmentofallergicresponsestocommonenvironmental
antigens, such as dust mites, fungi, cockroaches, and pollens.
Although abundant epidemiological studies support the
hygiene hypothesis, signiﬁcant inverse relations between
exposures to these compounds and atopy and asthma have
been found.
Protection from allergies is conferred by children grow-
ing up on small farms in parts of Europe [57], supporting
this hypothesis. The speciﬁc exposure responsible for the
protection against allergies aﬀorded by this rural lifestyle
is unknown, but most of the results have focused on
germs and their endotoxin, which can be measured in
Table 2: Interactions of genes with maternal atopy, endotoxin
and other environmental factors on IgE production and asthma
phenotype.
Environment factors-gene
interaction
Prenatal Cord blood
IgE levels
Maternal atopy-FGF1 [10]
Maternal atopy-IL13-CCL22 [10]
Maternal atopy-gender-
CTLA4 [46]
Endotoxin-CD14 [47]
Childhood
IgE levels
Animal contact-CD14 [48]
Helicobacter pylori-CD14 [49]
Endotoxin-CD14 [50]
Day care attendance-CD14 [51]
Day care attendance-IL4R [51]
Asthma
Country living-CD14 [52]
Fungi-CHIT1 [53]
Maternal bronchial
hyperresponsiveness-HLA-G [54]
Children of farmer-TLR2 [55]
house dust. Endotoxin, a component of the cell walls of
Gram-negative bacteria, is one of the pathogen-associated
molecular patterns (PAMPs). PAMPs, evolutionarily highly
conserved structural components of microbes, are recog-
nized by conserved receptors of innate immune systems,
pattern-recognition receptors (PRRs), the human CD14,
TLRs, nucleotide-binding oligomerization domain (NOD)-
1, NOD2, and C-type lectin receptors. Because the speciﬁc
agent responsible for the protective eﬀect against asthma in
children with a rural upbringing is unknown, the exposure
metric in some studies on gene-environment interaction on
IgE levels, allergies, or asthma in children growing up on
farms relies on self-reported contact with germs and other
animals, as listed in Table 2.
The relationship between endotoxin exposure and IgE
levels seems to be aﬀected by a common SNP in the
promoter region of CD14, a receptor involved in endotoxin
recognition[50].Asigniﬁcantgene-environmentinteraction
exists between the CD14 −260C/T genotype and endo-
toxin exposure on CD4+ lymphocyte numbers, particularly
CD4+Foxp3− lymphocytes at 1 year of age [47]. Interactions
of IL13 with IL4R, IL13R,o rCCL17,a sw e l la st h ei n t e r a c -
tions of CD14 with daycare attendance, endotoxin, or rural
living aﬀect IgE production and the development of asthma
in childhood [14–17, 21, 22, 50–52].
3.3.TobaccoSmokeExposure. Previousstudieshaveprovided
evidence on the role of tobacco smoke exposure (TSE) as
a determinant risk factor of childhood asthma [40, 75, 76].
Recent studies suggest that in utero TSE from maternal
smoking during pregnancy is associated with reduced lung
function and constitutes a signiﬁcant risk factor for the
development of asthma [75, 77–81]. This parent-of-origin4 Clinical and Developmental Immunology
Table 3: Interactions of genes with perinatal environmental TSE
and pollution on asthma development.
Stage Environment factors-gene interaction
Prenatal
TSE-Chromosome 1q43-q44, 4q34 and 17p11 [58]
TSE-ADAM33 [59]
TSE-B2AR [60]
TSE-GSTM1 [5, 61]
TSE-GSTP1 [62]
TSE-IL1RN [63]
TSE-IL13 [64]
Pollution-ACSL3 [65]
TSE and pollution-TGFB1 [66]
Childhood
TSE-Chromosome 3p and 5q [67]
TSE-Chromosome 1p, 1q, 5q, 9q and 17p [68]
TSE-Chromosome 1q43-q44, 4q34 and 17p11 [58]
TSE-B2AR [69]
TSE-CD14 [70]
TSE-GSTP1 [71]
TSE-GSTM1 [71]
TSE-TNF [72]
Pollution-GSTM1-TNF [73]
Pollution-GSTP1-TNF [73]
Pollution-Catalase genes-Myeloperoxidase genes [74]
eﬀect points to a signiﬁcant role of the maternal prenatal
environment on later asthma risk in the oﬀspring [82].
Early postnatal TSE from parents was also associated with
infant wheezing and lower respiratory tract infections and
increased the prevalence of asthma independently from
the eﬀect of in utero TSE from maternal smoking during
pregnancy[83].Moreover,theeﬀectofcurrentTSEisknown
not only to inﬂuence the severity of asthma, but also to
impair the eﬃcacy of inhaled corticosteroid treatments [84].
Although exposure to active and passive cigarette smoking is
a well-recognized risk factor for the development of asthma,
asthma manifests in only a portion of people [85, 86].
Furthermore, Jaakkola et al. showed that a combination of
parental atopy and TSE has a synergistic eﬀect on the risk
of childhood asthma [85]. This suggests that the eﬀect of
environmental factors on the development of asthma can be
modiﬁed by genetic constitution.
A number of candidate gene studies investigating inter-
actions with TSE have been performed for 3 main groups of
genes: innate-immunity genes (CD14, tumor necrotic factor
(TNF), and IL-1 receptor antagonist (IL1RN)), adaptive-
immunitygenes(IL13andtransforminggrowthfactor (TGF)-
β1), and response and remodeling genes (a disintegrin
and metalloprotease domain-containing protein (ADAM)-
33, glutathione S-transferase (GST)-M1, GSTP1,a n dβ2-
adrenergic receptor (B2AR)), as shown in Table 3. Timing of
exposure to TSE is also an important consideration in the
analysis of gene-environment interactions on the develop-
ment of childhood asthma. In the prenatal stage, the IL1RN
gene polymorphism rs2234678 GG genotype signiﬁcantly
increasedtherelativeriskofasthmaonlyinchildrenofmoth-
ers who smoked during pregnancy [63]. Reijmerink et al.
showed that ADAM33 polymorphisms increased the risk of
developingasthmainutero,butpostnatalTSEdidnot[59].A
GWA study demonstrated that the chromosomes 3p and 5q
werelinkedtochildhoodasthmaintobacco-exposedfamilies
[67]. Wang et al. [69] showed that the joint eﬀect of the
B2AR polymorphism at position 16 with TSE increased the
riskofasthmainadose-dependentmanner.Somegeneswere
only associated with asthma in the presence of TSE [63, 64].
In GSTM1-null children of school age, in utero exposure to
smoking is associated with an increased prevalence of early-
onset asthma, asthma with current symptoms, persistent
asthma, lifetime history of wheezing, wheezing with exercise,
wheezing requiring medication, and number of emergency
department visits in the past year in comparison to children
with the GSTM1+ genotype [61, 87, 88].
A recent study showed a synergistic eﬀect of air pol-
lution levels and functional SNPs within catalase and my-
eloperoxidase on the respiratory-related school absence of
asthmatic children [74]. The exposure-traﬃca i rp o l l u t a n t s
also increased the eﬀect of TGFB1 −509C/T polymorphism
on the development of asthma [66].
4. EnvironmentalInﬂuence of Epigenetic
Programmingfor IgE Production and
Asthma Development inthe PostnatalStage
Epigenetic programming is broadly deﬁned as heritable
changes in gene expression or cellular phenotype other
than changes in DNA sequences [95, 96]. Epigenetic alter-
ations are believed to occur not only prenatally or shortly
after birth, but also during later developmental periods,
inﬂuencing gene expression diﬀerentially throughout the
lifespan. Although GWA studies hold promise foridentifying
unexpected gene-environment interactions, how the gene-
environment interactions aﬀect IgE production and asthma
development remains unclear. One of the potential mech-
anisms is the epigenetic programming of asthma by gene-
environment interactions in the perinatal stage. Early-life
dietary supplementation and environmental exposures are
known to aﬀect adult metabolism and phenotype through
alterations in DNA CG methylation [97].
Several environmental exposures reportedly interact
with genetic predisposition through epigenetic mecha-
nisms on total IgE levels and asthma phenotype (Table 4).
Hollingsworth et al. are the ﬁrst to report an increased risk
of allergic disease in in utero dietary methyl donors because
of the diﬀerential methylation of 82 genes [90]. One of
these is runt-related transcription factor 3 (Runx3) ,ag e n e
known to downregulate allergic airway inﬂammation; it is
associatedwithdecreasedtranscriptional activityandmRNA
expression in lung tissue. DNA methylation levels of Runx3
increased in animals exposed to methyl donors in utero [90].
This eﬀect could be transmitted to subsequent progeny mice.
Runx3 is known to cooperate with T-bet in the silencing
of IL-4 in Th1 cells [98]. A reduced Runx3 level might
lead to enhanced transcription of IL-4 skewing toward Th2Clinical and Developmental Immunology 5
CH3 donors
Smoke Oxidative stress
Maternal atopy
Th2 genes methylation
Redox genes methylation
Development of
allergic diseases
(a) Prenatal stage
Allergic diseases
persistence
remission
O3 Hygiene Microbiota
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Treg Or
Th2 > Th1
(b) Postnatal stage
Figure 1: Mechanisms of pre- and postnatal environmental factors on the development of asthma. A number of prenatal factors such as
maternal diet with methyl donors, maternal atopy, TSE, and oxidative stress could alter the epigenetic programming of Th2 and redox
genes, resulting in the allergic sensitization and diseases (a). Additional postnatal environmental conditions such as pollution, secondhand
TSE, pets exposure, infant diets and microbiota may modulate or drive the expression of Treg and/or Th1/Th2 genes resulting in skewed or
balanced Th2 responses that contribute to persistence or remission of allergic diseases (b).
Table 4: Environmental modiﬁcation of epigenetic program on IgE
production and asthma.
Phenotypes Environment factors-epigenetic modiﬁcation
IgE levels
High-fat (HF) intake-obesity [89] murine
Maternal diet with methyl donors-82 loci [90]
murine
Aspergillus fumigatus-diesel exhaust particles
(DEP)-IL4 promoter [91] murine
Aspergillus fumigatus-diesel exhaust particles
(DEP)-IFNG promoter [91] murine
Asthma
Folic acid supplements in pregnancy [92]
Al w o ﬃi F78-IFNG promoter [93] murine
Maternal diet with methyl donors-82 loci [90]
murine
Pollution-ACSL3 [65]
Microbial exposure-IFNG [94]
diﬀerentiation, as observed in anti-CD3+CD28+ antibody-
stimulated CD4+ lymphocytes. Although the signiﬁcance of
epigenetic inheritance in humans is unclear, one recent study
reported that folate supplements in pregnancy are associated
with increased childhood wheezing [92]. In contrast, 2
cohort studies showed that dietary pattern during pregnancy
was not associated with recurrent wheezing [99] or asthma
and related outcomes [100].
Maternal smoking in pregnancy may feasibly impact the
development of allergic airway disease through epigenetic
pathways because of changes in DNA methylation or his-
tone modiﬁcations. Air pollution has been also linked to
epigenetic changes in ACSL3 [65]. Similarly, diesel exhaust
particles were shown to aﬀect CG methylation of IL4 and
IFNG promoters, which are involved in airway inﬂammation
[91].
5. Implications of Gene-Environment
Interactions on Prevention of Asthma
IgE production and asthma are not controlled by a single
gene, but are involved in a complex interaction with
environmental modiﬁcation of genetic and epigenetic pro-
gramming of asthma. Any individual study is unlikely to
be able to account for all of the complex interactions with
confounding factors in prenatal and postnatal stages and
from other host factors such as maternal diets, obesity, and
gender. Despite these limitations, the study of environmental
epigenetics promises to help us understand the theoreti-
cally preventable disease, asthma. Environmental changes
can epigenetically modulate Th2 and redox genes in the
prenatal stage and change the Treg function and/or skewed
Th2 immune reaction in the postnatal stage, as shown in
Figure 1.N o t a b l ed i ﬀerences in the immune responses of
allergic and nonallergic children are evident in utero,w h e r e
environmental exposures such as maternal diet with methyl
donors, maternal atopy, TSE, and oxidative stress could
alter the epigenetic programming of Th2 and redox genes,
resulting in allergic sensitization and diseases (Figure 1(a)).
Additional postnatal environmental conditions such as pol-
lution, secondhand TSE, pet exposure, infant diets, and
microbiota may modulate or drive the expression of Treg
and/or Th1/Th2 genes, resulting in skewed or balanced
Th2 responses that contribute to persistence or remission
of allergic diseases (Figure 1(b)). Based on the mecha-
nisms responsible for the perinatal epigenetic and immune
regulation of the development and remission of allergic
diseases, we may be able to formulate potential strategies6 Clinical and Developmental Immunology
to prevent the development of asthma in the perinatal
stage by manipulating perinatal conditions such as diet
control or complementary food and by early screening of
DNA methylation changes followed by modulation of CG
methylation levels.
6. Conclusion
Increasingly, more evidence suggests that diﬀerent gene-
environment interactions play an important role on IgE
productionbeforeandafterbirth.Weconductedasystematic
review of recent studies to identify the roles of gene-gene
and gene-environmental interactions on the prenatal and
childhood IgE production, as well as the development of
asthma. Prevention of IgE production and IgE-mediated
diseases may be possible by controlling diﬀerent envi-
ronmental factors for patients with susceptible genotypes
early in the perinatal stage. Control of maternal atopy
in pregnancy and modulation of gene expression such as
CTLA4 and IL13 may be a target for decreasing antenatal
IgE production and possibly lowering perinatal allergy sen-
sitization. TSE is a well-recognized risk for the development
of childhood asthma; reducing the perinatal exposure of
tobacco smoke may prevent the development of asthma,
particularly in subjects carrying susceptible Th2 and redox
genotypes. Further studies are necessary to compare gene-
gene and gene-environment interactions on IgE production
and asthma development in diﬀerent ethnic populations
and to study whether manipulations of maternal diets or
postnatal complementary food could modulate epigenetic
programming of asthma.
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